Back to search

Ireland· IE-PA-PA1353/006/001

Treposuvi 1 mg/ml solution for infusion

A treprostinil product containing treprostinil, registered in Ireland by Orpha-Devel Handels und Vertriebs GmbH. The same ATC class is registered in 17 of our 19 countries.

ATC B01AC21

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTreposuvi 1 mg/ml solution for infusi…ATCB01AC21REGISTER NO.IE-PA-PA1353/006/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Treprostinil is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AC21 (treprostinil), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 9 of them publish a price we can compare per daily dose

Treprostinil · ATC B01AC21

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Treprostinil
Manufacturer
Orpha-Devel Handels und Vertriebs GmbH
Country
Ireland (IE)
ATC code
B01AC21
ATC class
Treprostinil
Defined daily dose
4.3 mg, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1353/006/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

371 interactions on record for treprostinil.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Treprostinil · interactions on record

371 records

  • 34 severe
  • 295 moderate
  • 2 minor
  • 40 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Treprostinil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All treprostinil products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Remodulin, Treposa
  • Belgium · Remodulin, Tresuvi
  • Bulgaria · Тресуви
  • Cyprus · Remodulin
  • Czechia · Remodulin, Treprostinil Tillomed
  • Germany · Remodulin, Treprostinil Beta
  • Denmark · Remodulin, Treprostinil Tillomed
  • Estonia · Remodulin, Tresuvi
  • Spain · Treprostinilo Dr. Reddys, Treprostinilo Ferrer
  • Finland · Remodulin, Treposa
  • France · Remodulin, Treposuvi
  • United Kingdom (Northern Ireland) · Treprostinil Dr. Reddy's Laboratories (Uk), Treprostinil Tillomed
  • Greece · Remodulin, Treprostinil Tillomed
  • Croatia · Remodulin, Treprostinil Tillomed
  • Hungary · Remodulin, Treprostinil Zentiva
  • Iceland · Remodulin, Trepulmix
  • Italy · Remodulin, Treprostinil Dr. Reddy’s
  • Liechtenstein · Trepulmix
  • Lithuania · Remodulin, Treprostinil Tillomed
  • Luxembourg · Remodulin
  • Latvia · Remodulin, Treposuvi
  • Malta · Tresuvi
  • Netherlands · Remodulin, Treposuvi
  • Norway · Remodulin, Treprostinil Tillomed
  • Poland · Remodulin, Treprostinil Reddy
  • Portugal · Remodulin, Treprostinilo Tillomed
  • Romania · Tresuvi
  • Sweden · Remodulin, Treprostinil Tillomed
  • Slovenia · Remodulin, Treprostinil Amomed
  • Slovakia · Remodulin, Treprostinil Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5e66443-ff3c-455b-b186-08e135fb4404
GET /v1/drugs/f5e66443-ff3c-455b-b186-08e135fb4404?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Intravenous use",
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B01AC21"
  ],
  "strength": null,
  "pa_number": "PA1353/006/001",
  "substances": [
    "Treprostinil"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "07/05/2021",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about treprostinil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.